I agree that this site is using cookies. You can find further informations here.
X
Fabian, Kellsye P.
30  results:
Search for persons X
?
1

A landscape of checkpoint blockade resistance in cancer: un..:

Santiago-Sánchez, Ginette S. ; Fabian, Kellsye P. ; Hodge, James W.
Cancer Biology & Therapy.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

Chordoma cancer stem cell subpopulation characterization ma..:

Lopez, Diana C. ; Fabian, Kellsye P. ; Padget, Michelle R....
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Exploiting docetaxel-induced tumor cell necrosis with tumor..:

Franks, S. Elizabeth ; Santiago-Sanchez, Ginette S. ; Fabian, Kellsye P....
Cancer Immunology, Immunotherapy.  72 (2023)  8 - p. 2783-2797 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Dying of Stress: Chemotherapy, Radiotherapy, and Small-Mole..:

Fabian, Kellsye P. ; Kowalczyk, Joshua T. ; Reynolds, Sandy T..
Cells.  11 (2022)  23 - p. 3826 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Exploiting the immunogenic potential of standard of care ra..:

Kowalczyk, Joshua T ; Fabian, Kellsye P ; Padget, Michelle R...
Journal for ImmunoTherapy of Cancer.  10 (2022)  12 - p. e005752 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Immune targeting of three independent suppressive pathways ..:

Franks, S. Elizabeth ; Fabian, Kellsye P. ; Santiago-Sánchez, Ginette..
OncoImmunology.  11 (2022)  1 - p. , 2022
Link: https://doi.org/10.1080/..
 
?
7

Tipping the scales: Immunotherapeutic strategies that disru..:

Santiago-Sánchez, Ginette S. ; Hodge, James W. ; Fabian, Kellsye P.
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
8

Differential combination immunotherapy requirements for inf..:

Fabian, Kellsye P ; Padget, Michelle R ; Fujii, Rika..
Journal for ImmunoTherapy of Cancer.  9 (2021)  2 - p. e001691 , 2021
Link: https://doi.org/10.1136/..
 
?
9

Combinatorial Natural Killer Cell–based Immunotherapy Appro..:

Hoke, Austin T.K. ; Padget, Michelle R. ; Fabian, Kellsye P....
Cancer Research Communications.  1 (2021)  3 - p. 127-139 , 2021
Link: https://doi.org/10.1158/..
 
?
10

The emerging role of off-the-shelf engineered natural kille..:

Fabian, Kellsye P. ; Hodge, James W.
Molecular Therapy - Oncolytics.  23 (2021)  - p. 266-276 , 2021
Link: https://doi.org/10.1016/..
 
?
11

From Immunogenic Cell Death to Immunogenic Modulation: Sele..:

Fabian, Kellsye P. ; Wolfson, Benjamin ; Hodge, James W.
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
12

Tumor control via targeting PD-L1 with chimeric antigen rec..:

Robbins, Yvette ; Greene, Sarah ; Friedman, Jay...
eLife.  9 (2020)  - p. , 2020
Link: https://doi.org/10.7554/..
 
?
13

PD-L1 targeting high-affinity NK (t-haNK) cells induce dire..:

Fabian, Kellsye P ; Padget, Michelle R ; Donahue, Renee N....
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000450 , 2020
Link: https://doi.org/10.1136/..
 
?
14

Overcoming hypoxia-induced functional suppression of NK cel..:

Solocinski, Kristen ; Padget, Michelle R ; Fabian, Kellsye P...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000246 , 2020
Link: https://doi.org/10.1136/..
 
?
15

Impact of combination immunochemotherapies on progression o..:

Ludwig, Sonja ; Hong, Chang-Sook ; Razzo, Beatrice M....
Cancer Immunology, Immunotherapy.  68 (2019)  7 - p. 1133-1141 , 2019
Link: https://doi.org/10.1007/..
 
1-15